| # | Drug | Count |
|---|---|---|
| 0 | ADALIMUMAB | 26 |
| 1 | ETANERCEPT | 22 |
| 2 | RITUXIMAB | 22 |
| 3 | METHOTREXATE SODIUM | 21 |
| 4 | METHOTREXATE | 18 |
| 5 | HYDROXYCHLOROQUINE SULFATE | 17 |
| 6 | PREDNISONE | 14 |
| 7 | EPINEPHRINE | 12 |
| 8 | OMALIZUMAB | 11 |
| 9 | OXALIPLATIN | 11 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | FLUORESCEIN SODIUM | 2 | 0.0065 |
| 1 | LATANOPROST OPHTHALMIC SOLUTION 0.005% | 1 | 0.0016 |
| 2 | GARADACIMAB | 1 | 0.0013 |
| 3 | DIFLUNISAL | 1 | 0.0012 |
| 4 | GADOTERATE MEGLUMINE | 4 | 0.0011 |
| 5 | OMEPRAZOLE, SODIUM BICARBONATE | 1 | 0.0010 |
| 6 | OMEPRAZOLE 20MG | 1 | 0.0009 |
| 7 | FOSNETUPITANT AND PALONOSETRON | 1 | 0.0008 |
| 8 | NETUPITANT AND PALONOSETRON | 1 | 0.0008 |
| 9 | IOHEXOL | 7 | 0.0008 |
| # | Drug class | Count |
|---|---|---|
| 0 | Tumor Necrosis Factor Blocker [EPC] | 31 |
| 1 | CD20-directed Cytolytic Antibody [EPC] | 24 |
| 2 | Corticosteroid [EPC] | 23 |
| 3 | Folate Analog Metabolic Inhibitor [EPC] | 18 |
| 4 | Nonsteroidal Anti-inflammatory Drug [EPC] | 17 |
| 5 | Platinum-based Drug [EPC] | 15 |
| 6 | Catecholamine [EPC] | 13 |
| 7 | alpha-Adrenergic Agonist [EPC] | 12 |
| 8 | beta-Adrenergic Agonist [EPC] | 12 |
| 9 | Anti-IgE [EPC] | 11 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Guanylate Cyclase-C Agonist [EPC] | 1 | 0.0005 |
| 1 | Gadolinium-based Contrast Agent [EPC] | 2 | 0.0004 |
| 2 | Radiographic Contrast Agent [EPC] | 9 | 0.0003 |
| 3 | Sulfonamide Antibacterial [EPC] | 1 | 0.0003 |
| 4 | Substance P/Neurokinin-1 Receptor Antagonist [EPC] | 2 | 0.0002 |
| 5 | Paramagnetic Contrast Agent [EPC] | 1 | 0.0002 |
| 6 | Progestin Antagonist [EPC] | 1 | 0.0002 |
| 7 | Catecholamine [EPC] | 13 | 0.0002 |
| 8 | Tetracycline-class Antibacterial [EPC] | 1 | 0.0001 |
| 9 | Anti-IgE [EPC] | 11 | 0.0001 |